Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Urban

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|December 6, 2012
Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytesAnja Meier, Stefan Mehrle, Thomas S Weiss, et al.
Antiviral Therapy|November 15, 2017
Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitroAntje Blank, Katrin Meier, Stephan Urban, et al.
Hepatology (Baltimore, Md.)|February 4, 2023
Hepatitis delta: Epidemiology to recent advances in therapeutic agentsNehna Abdul Majeed, Benno Zehnder, Christopher Koh, et al.
Molecular Pharmaceutics|April 23, 2013
Liver imaging with a novel hepatitis B surface protein derived SPECT-tracerThomas Müller, Stefan Mehrle, Alexa Schieck, et al.
Molecules (Basel, Switzerland)|July 27, 2010
Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitorAlexa Schieck, Thomas Müller, Andreas Schulze, et al.
BMB Reports|October 1, 2008
An anti-viral peptide derived from the preS1 surface protein of hepatitis B virusDo-Hyoung Kim, Yi Ni, Si-Hyung Lee, et al.
Scientific Reports|October 6, 2021
Concentration of Na<sup>+</sup>-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virusAndreas Oswald, Anindita Chakraborty, Yi Ni, et al.
Viruses|June 27, 2024
Analysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like AgentsGnimah Eva Gnouamozi, Zhenfeng Zhang, Vibhu Prasad, et al.
Journal of Virology|September 21, 2018
T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCRBingqian Qu, Yi Ni, Florian A Lempp, et al.
Journal of Hepatology|November 19, 2015
Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factorFlorian A Lempp, Pascal Mutz, Christoph Lipps, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|December 6, 2012
Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytesAnja Meier, Stefan Mehrle, Thomas S Weiss, et al.
Antiviral Therapy|November 15, 2017
Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitroAntje Blank, Katrin Meier, Stephan Urban, et al.
Hepatology (Baltimore, Md.)|February 4, 2023
Hepatitis delta: Epidemiology to recent advances in therapeutic agentsNehna Abdul Majeed, Benno Zehnder, Christopher Koh, et al.
Molecular Pharmaceutics|April 23, 2013
Liver imaging with a novel hepatitis B surface protein derived SPECT-tracerThomas Müller, Stefan Mehrle, Alexa Schieck, et al.
Molecules (Basel, Switzerland)|July 27, 2010
Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitorAlexa Schieck, Thomas Müller, Andreas Schulze, et al.
BMB Reports|October 1, 2008
An anti-viral peptide derived from the preS1 surface protein of hepatitis B virusDo-Hyoung Kim, Yi Ni, Si-Hyung Lee, et al.
Scientific Reports|October 6, 2021
Concentration of Na<sup>+</sup>-taurocholate-cotransporting polypeptide expressed after in vitro-transcribed mRNA transfection determines susceptibility of hepatoma cells for hepatitis B virusAndreas Oswald, Anindita Chakraborty, Yi Ni, et al.
Viruses|June 27, 2024
Analysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like AgentsGnimah Eva Gnouamozi, Zhenfeng Zhang, Vibhu Prasad, et al.
Journal of Virology|September 21, 2018
T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCRBingqian Qu, Yi Ni, Florian A Lempp, et al.
Journal of Hepatology|November 19, 2015
Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factorFlorian A Lempp, Pascal Mutz, Christoph Lipps, et al.
Pageof 14